share_log

Recursion Pharmaceuticals | 144/A: Others

Recursion Pharmaceuticals | 144/A: Others

Recursion Pharmaceuticals | 144/A:其他
美股SEC公告 ·  04/16 17:01
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at approximately $191,658.73, were originally acquired on 04/20/2021 through a pre-IPO option exercise directly from the issuer. The transaction is part of a planned sale that was adopted on 03/01/2023. Over the past three months, Secora Michael has sold a total of 150,000 shares, generating gross proceeds of $1,562,683.24.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares on 04/16/2024, as per the latest filing. The shares, valued at approximately $191,658.73, were originally acquired on 04/20/2021 through a pre-IPO option exercise directly from the issuer. The transaction is part of a planned sale that was adopted on 03/01/2023. Over the past three months, Secora Michael has sold a total of 150,000 shares, generating gross proceeds of $1,562,683.24.
根据最新文件,Recursion Pharmicals, Inc.高管塞科拉·迈克尔定于2024年4月16日出售25,000股A类股票。这些股票的价值约为191,658.73美元,最初是在2021年4月20日通过首次公开募股前的期权行使直接从发行人手中收购的。该交易是2023年1月3日通过的计划出售的一部分。在过去的三个月中,Secora Michael共出售了15万股股票,总收益为1,562,683.24美元。
根据最新文件,Recursion Pharmicals, Inc.高管塞科拉·迈克尔定于2024年4月16日出售25,000股A类股票。这些股票的价值约为191,658.73美元,最初是在2021年4月20日通过首次公开募股前的期权行使直接从发行人手中收购的。该交易是2023年1月3日通过的计划出售的一部分。在过去的三个月中,Secora Michael共出售了15万股股票,总收益为1,562,683.24美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息